Atopic dermatitis, Crohn's disease, irritable bowel syndrome, ulcerative colitis, chemotherapy-associated diarrhea, intestinal dysbiosis, etc
Conditions
Interventions
Immunocompromised group:None
Sponsors
The First Affiliated Hospital of Guangdong Pharmaceutical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age: 18 years old= patient age= 75 years old; (2) Gender: Gender is not limited (3) Patients who have undergone WMT treatment for the first time in our hospital and have completed at least two courses of WMT treatment; (4) Understand the purpose of this study and voluntarily participate in this study; (5) No antibiotics, immunosuppressants and other drugs were taken during WMT treatment.
Exclusion criteria
Exclusion criteria: (1) Those who have abnormal speech expression and cannot take care of themselves; (2) pregnant or lactating women; (3) Those who have poor compliance and do not cooperate with the clinical treatment plan.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Complete blood count;Lymphocyte subsets;6 items of rheumatic immunity; | — |
Countries
China
Contacts
Public ContactHe Xingxiang
The First Affiliated Hospital of Guangdong Pharmaceutical University
Outcome results
None listed